APOLLOMICS
Apollomics, Inc. is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The companyโs existing pipeline consists of several development-stage assets, including novel, humanized monoclonal antibodies that restore the bodyโs immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.
APOLLOMICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.apollomicsinc.com
Total Employee:
11+
Status:
Active
Contact:
+1-650-209-4055
Total Funding:
238.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ping An Capital
Ping An Capital investment in Series C - Apollomics
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Apollomics
Junson Capital
Junson Capital investment in Series B - Apollomics
Guangzhou Yue Min Investment
Guangzhou Yue Min Investment investment in Series B - Apollomics
OrbiMed
OrbiMed investment in Series B - Apollomics
K2VC
K2VC investment in Series B - Apollomics
South China Venture Capital
South China Venture Capital investment in Series B - Apollomics
Pan-Lin Capital
Pan-Lin Capital investment in Series B - Apollomics
OrbiMed
OrbiMed investment in Series A - Apollomics
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-01-17 | MabPlex International | Apollomics investment in Series A - MabPlex International | 400 M CNY |
Official Site Inspections
http://www.apollomicsinc.com
- Host name: 104.26.0.173
- IP address: 104.26.0.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago